Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Country/Region as subject
Affiliation country
Publication year range
1.
Zhongguo Zhen Jiu ; 34(7): 719-20, 2014 Jul.
Article in Chinese | MEDLINE | ID: mdl-25233671

ABSTRACT

To further explore the clinical effect of massage therapy on navel,the related ancient literatures were arranged and analyzed,and several methods in ancient clinical were introduced, including stroking navel, rubbing navel, pushing navel, tapping navel and puffing navel. In addition, the theoretical basis of massage therapy on navel were discussed. The results revealed ancient literatures offered abundant theoretical basis to modern clinical practice, and there were evidences of treating gastroenteric and gynecological diseases with this therapy. Comprehensively, through the study of ancient literatures and modern research, therapy of massage on navel is believed to be promising and will gain popularity in the future.


Subject(s)
Massage/history , Umbilicus/physiopathology , China , History, Ancient , Humans , Medicine in Literature
2.
Pharmazie ; 68(5): 355-8, 2013 May.
Article in English | MEDLINE | ID: mdl-23802433

ABSTRACT

This study aimed to investigate the effects of rosuvastatin on TGF-beta1 expression, cardiac fibrosis, ventricular remodeling and cardiac function in diabetic cardiomyopathy rats. Twenty-seven diabetic rats induced by streptozotocin intraperitoneal injection were randomly divided into three groups, viz. diabetic, rosuvastatin low-dose (Ros-L) and high dose group (Ros-H). Intervention group were given rosuvastatin 2 mg/kg/d and 5 mg/kg/d orally, respectively. After 10 weeks, the levels of glycosylated hemoglobin (HbA1c), creatine phosphokinase isoenzyme (CK-MB), plasma brain natriuretic peptide (BNP), myocardial collagen volume fraction (CVF) and left ventricular mass index (LVWI) were measured. CK-MB levels in Ros-H and Ros-L rats were lower than in the diabetic group. Rosuvastatin alleviated myofibrosis cordis and fibroplastic proliferation. LVWI, BNP, CVF and TGF-beta1 mRNA and protein levels in the diabetic group were higher than in the control, but were reduced after rosuvastatin treatment. These results demonstrate that rosuvastatin dose-dependently reduces TGF-beta1 expression and inhibits the development of myocardial fibrosis in diabetic cardiomyopathy.


Subject(s)
Cardiomyopathies/drug therapy , Diabetic Cardiomyopathies/drug therapy , Fluorobenzenes/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Pyrimidines/pharmacology , Sulfonamides/pharmacology , Transforming Growth Factor beta1/antagonists & inhibitors , Transforming Growth Factor beta1/biosynthesis , Animals , Body Weight/drug effects , Cardiomyopathies/pathology , Collagen/metabolism , Creatine Kinase/metabolism , Diabetes Mellitus, Experimental/drug therapy , Diabetic Cardiomyopathies/pathology , Fibrosis , Glycated Hemoglobin/metabolism , Hypertrophy, Left Ventricular/pathology , Hypertrophy, Left Ventricular/prevention & control , Male , Natriuretic Peptide, Brain/metabolism , Rats , Rats, Wistar , Real-Time Polymerase Chain Reaction , Rosuvastatin Calcium
SELECTION OF CITATIONS
SEARCH DETAIL